JPRN-UMIN000015694已完成1 期
Safety and efficacy of haploidentical hematopoietic stem-cell transplantation followed by post-transplant high-dose cyclophosphamide (RIC) - Tsukuba-Haplo RIC
niversity of Tsukuba, Department of Hematology0 个研究点目标入组 10 人开始时间: 2015年1月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with anti-HLA antibody 2) Patients with uncontrollable psychological complications 3) Patients with active double cancer 4) Patients with uncontrollable active infection 5) Pregnant women 6) Patients who are judged inappropriate by investigators
研究者
相似试验
已完成
1 期
Safety and efficacy of haploidentical hematopoietic stem-cell transplantation followed by post-transplant high-dose cyclophosphamidehematological malignancyJPRN-UMIN000006631niversity of Tsukuba, Department of Hematology25
Unknown
4 期
Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia MajorThalassemia MajorNCT03171831First Affiliated Hospital of Guangxi Medical University30
已完成
不适用
Safety and efficacy of allogeneic hematopoietic stem cell transplantation for refractory hematological malignancies with plerixafor-combined myeloablative conditioningacute leukemia, myelodysplastic syndrome, chronic myelogenous leukemiaJPRN-UMIN000009485Division of Hematology Keio University School of Medicine12
尚未招募
不适用
Efficacy and safety of allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis in higher-risk myelodysplastic syndrome, chronic myelomonocytic leukemia, and secondary AML patientsKCT0004151Asan Medical Center113
已完成
1 期
Haploidentical hematopoietic stem cell transplantation in combination with posttransplant cyclophosphamide and ATG-thymoglobulin Phase I studyhematological malignancyJPRN-UMIN000009374ational Cancer Center Hospital15